Corbus Pharmaceuticals Stock (NASDAQ: CRBP)

Corbus Pharmaceuticals (NASDAQ:CRBP) Stock, Unusual Options

Corbus Pharmaceuticals

Corbus Pharmaceuticals Holdings, Inc. - Common Stock

Overview

News

Earnings

Options

Analyst Ratings

Insider Trades

Short Interest

Stock Report

Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

Comments

Corbus Pharmaceuticals Unusual Options